Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rosell

Showing results (241-250 of 265) with videos related to

Pageof 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancerD Isla, C Sarries, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patientsR de las Peñas, M Sanchez-Ronco, V Alberola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohortJ Mazières, F Barlesi, T Filleron, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2014
Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorderDaniel R Rosell, Lauren C Zaluda, Margaret M McClure, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trialC Camps, B Massuti, A Jiménez, et al.
Sensors (Basel, Switzerland)|December 14, 2011
Innovative LIDAR 3D Dynamic Measurement System to estimate fruit-tree leaf areaRicardo Sanz-Cortiella, Jordi Llorens-Calveras, Alexandre Escolà, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2015
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)S Ramalingam, G Goss, R Rosell, et al.
The European Respiratory Journal|July 3, 2010
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutationR Porta, J M Sánchez-Torres, L Paz-Ares, et al.
Lung Cancer (Amsterdam, Netherlands)|July 15, 2010
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbineN Viñolas, M Provencio, N Reguart, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesT Le Chevalier, G Scagliotti, R Natale, et al.
Pageof 27

Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancerD Isla, C Sarries, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patientsR de las Peñas, M Sanchez-Ronco, V Alberola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohortJ Mazières, F Barlesi, T Filleron, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2014
Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorderDaniel R Rosell, Lauren C Zaluda, Margaret M McClure, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trialC Camps, B Massuti, A Jiménez, et al.
Sensors (Basel, Switzerland)|December 14, 2011
Innovative LIDAR 3D Dynamic Measurement System to estimate fruit-tree leaf areaRicardo Sanz-Cortiella, Jordi Llorens-Calveras, Alexandre Escolà, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2015
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)S Ramalingam, G Goss, R Rosell, et al.
The European Respiratory Journal|July 3, 2010
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutationR Porta, J M Sánchez-Torres, L Paz-Ares, et al.
Lung Cancer (Amsterdam, Netherlands)|July 15, 2010
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbineN Viñolas, M Provencio, N Reguart, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesT Le Chevalier, G Scagliotti, R Natale, et al.
Pageof 27